SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-139930
Filing Date
2020-12-28
Accepted
2020-12-28 19:44:29
Documents
1
Period of Report
2020-12-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2039232-3_3.html 3  
1 OWNERSHIP DOCUMENT tm2039232-3_3.xml 3 2558
  Complete submission text file 0001104659-20-139930.txt   3989
Mailing Address 22 ORIOLE AVENUE BRONXVILLE NY 10708
Business Address
Weild IV David (Reporting) CIK: 0001648023 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39788 | Film No.: 201419751

Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Issuer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations